Clinical Trials on Gastroenteritis Escherichia Coli in Japan

Total 226 results

UMC Utrecht
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2) (EXPECT-2)

E. Coli Infection

United States, Italy, United Kingdom, Canada, France, Germany, Japan, Spain
Janssen Research & Development, LLC

Recruiting

A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

United States, United Kingdom, Korea, Republic of, Taiwan, Canada, Denmark, France, Thailand, New Zealand, Spain, China, Israel, Germany, Colombia, India, Netherlands, Australia, Japan, Sweden, Czechia, Italy
MJM Bonten
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1) (EXPECT-1)

E.Coli Infections

United States, United Kingdom, Canada, France, Germany, Italy, Japan, Spain
Takeda

Recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

Crohn's Disease

Japan
Showa Inan General Hospital

Completed

The Effectiveness of an Exclusive Cold Snare Polypectomy Snare for the Removal of Diminutive Colorectal Polyps

Postpolypectomy Bleeding | Diminutive Colorectal Polyp | Cold Snare Polypectomy | Polypectomy Snare | Complete Resection Rate

Japan
Hamamatsu University

Completed

Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication

Gastritis Associated With Helicobacter Pylori

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

Crohn's Disease

Japan
Takeda

Recruiting

A Survey of Darvadstrocel in People With Crohn's Disease (J-INSPIRE)

Crohn's Disease

Japan
Tokyo Medical and Dental University

Active, not recruiting

Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease

Crohn Disease

Japan
HilleVax

Active, not recruiting

Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants

Gastroenteritis

Japan
GlaxoSmithKline

Completed

Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis

Infections, Rotavirus | Rotavirus Vaccines

Japan
Zeria Pharmaceutical

Completed

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

Esophagitis, Reflux

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)

Crohn's Disease

Japan
Takeda

Active, not recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

Ulcerative Colitis

Japan
Kyoto University, Graduate School of Medicine
National Institute of Biomedical Innovation

Terminated

Therapeutic Study of ONO-4819CD for Ulcerative Colitis

Ulcerative Colitis

Japan
Pfizer

Completed

Xeljanz Special Investigation for Long-term Use in UC Patients

Ulcerative Colitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis

Bacterial Enteritis

Korea, Republic of, Singapore, Japan
Kissei Pharmaceutical Co., Ltd.

Recruiting

An Early Phase 2 Clinical Study of KSP-0243

Colitis, Ulcerative

Japan
Pfizer

Completed

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Crohn's Disease | Ulcerative Colitis

Japan
Sanofi

Completed

Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan

Cold Agglutinin Disease

Japan
Showa Inan General Hospital

Recruiting

Association Between LRG and Histologic Remission in Ulcerative Colitis

Ulcerative Colitis in Histologic Remission

Japan
Chikara Tashiro

Completed

Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening

Inflammatory Bowel Disease | Pancreas Disease | Hepatobiliary Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis

Healthy Men and Subjects With Ulcerative Colitis

Japan
Kyorin Pharmaceutical Co.,Ltd

Completed

Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA

Ulcerative Colitis

Japan
Takeda

Completed

Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"

Reflux Esophagitis

Japan
Comprehensive Support Project for Oncology Research
Novartis Pharmaceuticals

Completed

Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT

Breast Cancer

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease

Pediatric Crohn's Disease

Japan
Hamamatsu University
Yokoyama Foundation for Clinical Pharmacology

Unknown

Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori

Gastritis | Helicobacter Infections | Gastric Ulcer | Duodenal Ulcer

Japan
Astellas Pharma Inc

Completed

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

Ulcerative Colitis

Japan
AstraZeneca

Completed

BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects

Gastric Ulcer | Duodenal Ulcer | Reflux Esophagitis | Anastomotic Ulcer | Etc.

Japan
Hamamatsu University

Unknown

Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection

Gastritis | Helicobacter Infections | Gastric Ulcer | Duodenal Ulcer

Japan
Takeda

Completed

Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"

Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Crohn's Disease

France, Israel, Italy, Netherlands, Poland, Slovakia, Ukraine, Czech Republic, Germany, Hungary, Japan
Pfizer

Completed

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

Arthritis, Rheumatoid | Psoriasis | Crohn Disease | Colitis, Ulcerative

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Extension Study of MT-1303 in Subjects With Crohn's Disease

Crohn's Disease

Czechia, France, Germany, Hungary, Israel, Italy, Japan, Netherlands, Poland, Slovakia, Ukraine
Otsuka Pharmaceutical Co., Ltd.

Terminated

A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease

Crohn Disease

Japan
R&R Inc.

Completed

Phase II Study of RR110 in Patients With Active Crohn's Disease

Crohn's Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis

Pediatric Ulcerative Colitis

Japan
Boehringer Ingelheim

Terminated

A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction

Fibrostenotic Crohn´s Disease

United States, Canada, Japan, Sweden
Sanofi

Recruiting

Cold Agglutinin Disease Real World Evidence Registry (CADENCE)

Cold Agglutinin Disease (CAD) | Cold Agglutinin Syndrome (CAS)

United States, Austria, France, Italy, Germany, Japan, Spain, United Kingdom
Otsuka Pharmaceutical Co., Ltd.

Completed

An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis

Colitis, Ulcerative

Japan
Abbott
Eisai Co., Ltd.

Completed

A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease

Crohn's Disease

Japan
Abbott
Eisai Co., Ltd.; Abbott Japan Co.,Ltd

Completed

A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease

Crohn's Disease

Japan
Chinese University of Hong Kong

Recruiting

AG & IM in CA Stomach Protocol

Gastric Cancer | Intestinal Metaplasia | Atrophic Gastritis

Hong Kong, Japan, Singapore, Thailand
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer

Head and Neck Cancer

Japan
Astellas Pharma Inc

Completed

Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

Ulcerative Colitis

Japan
Taiho Pharmaceutical Co., Ltd.
UCB Pharma

Completed

Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -

Gastroesophageal Reflux

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease

Crohn's Disease

Korea, Republic of, Japan
Bioverativ, a Sanofi company

Completed

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)

Agglutinin Disease, Cold

United States, Israel, Australia, Spain, Austria, Germany, Belgium, France, Canada, Italy, Japan, Norway, Netherlands, United Kingdom
Takeda

Completed

A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis

Erosive Esophagitis

Japan

Clinical Trials on Gastroenteritis Escherichia Coli in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations